• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS 6000; CHEMISTRY ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS 6000; CHEMISTRY ANALYZER Back to Search Results
Model Number COBAS 6000
Device Problems Low Test Results (2458); Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/20/2014
Event Type  No Answer Provided  
Event Description
Roche was aware that their cobas 6000 is running approximately 3 mmol/l lower than the roche cobas 8000.However the materials provided with the cobas 6000 failed to disclose these differences prior to us reporting patient results and the reference intervals for both platforms provided by roche are the same.Physicians in our institution began to complain that sodium results began to run consistently lower following the cobas 6000 going live earlier this year.Follow up patient comparison with a cobas 8000 in operation at a major local medical institution showed that comparison of sodium results on patient samples run on the cobas 6000 were 3.1 mmol/l lower than that run on the cobas 8000.The difference in sodium results between the two roche platforms should have been brought to our attention prior to going live, and the failure to do this resulted in substantial additional effort in our chemistry service, and resulted in a major concern by clinicians regarding what appeared to be a marked increase in hyponatremia that was ultimately proven to be the result of instrument bias with the roche 6000.The failure of the manufacturer to notify accounts using the roche 6000 regarding this biased result for sodium has the potential of leading to unnecessary sodium supplementation in patients evaluated on the roche 6000 platform.
=
manufacturer response for chemistry analyzer, cobas 6000 (per site reporter).
=
roche can not officially recommend eliminating the compensation on the 6000, as that is how the system was approved by the fda.They are suggesting that with any modification to an approved system the customer would be responsible for validating it.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS 6000
Type of Device
CHEMISTRY ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague rd,
indianapolis, IN 46250
MDR Report Key3732865
MDR Text Key16913599
Report Number3732865
Device Sequence Number0
Product Code CEM
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Type of Report Initial
Report Date 02/26/2014
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Device Operator Invalid Data
Device Model NumberCOBAS 6000
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA03/27/2014
Event Location Hospital
Date Report to Manufacturer04/08/2014
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/27/2014
Patient Sequence Number1
-
-